CLAIM #20577 · DHR (DHR) · 2022Q3 earnings call · Oct 20, 2022 · due Dec 31, 2023
“As we think about the Bioprocessing business for 2023, we still think that there is room for $500 million of COVID opportunity in order to support the needs of the population, the variance to replenish expired sell-by dates and all the things that you can think about.”
Rainer Blair · CEO
PENDING
graded after results covering Dec 31, 2023 are reported
Verify independently
SEC filings for DHR ↗ · Claim quote is verbatim from the 2022Q3 earnings call.